Evidence map›Paper›PMID 24108697›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

MAIT recognition of a stimulatory bacterial antigen bound to MR1.

Jacinto López-Sagaseta, Charles L Dulberger, Amanda McFedries, Mark Cushman, Alan Saghatelian, Erin J Adams

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Ligand-dependent downregulation of MR1 cell surface expression.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. MR1-dependent antigen presentation.Seminars in cell & developmental biology · 2018
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jacinto López-SagasetaDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637;
Charles L Dulberger
Amanda McFedries
Mark Cushman
Alan Saghatelian
Erin J Adams
University of Chicago · USHarvard University · USPurdue University West Lafayette · US

Funding

Molecular Recognition of Ligand by the Gamma Delta T Cell ReceptorR01AI073922 · NIAID · UNIVERSITY OF CHICAGO · PI ADAMS, ERIN JUNE · 2007 to 2016
$3.8M
NIAID NIH HHS R01 AI073922NIAID NIH HHS R01AI073922
6 · The paper itself

Abstract

MR1-restricted mucosal-associated invariant T (MAIT) cells represent a subpopulation of αβ T cells with innate-like properties and limited TCR diversity. MAIT cells are of interest because of their reactivity against bacterial and yeast species, suggesting that they play a role in defense against pathogenic microbes. Despite the advances in understanding MAIT cell biology, the molecular and structural basis behind their ability to detect MR1-Ag complexes is unclear. In this study, we present our structural and biochemical characterization of MAIT TCR engagement of MR1 presenting an Escherichia coli-derived stimulatory ligand, rRL-6-CH2OH, previously found in Salmonella typhimurium. We show a clear enhancement of MAIT TCR binding to MR1 due to the presentation of this ligand. Our structure of a MAIT TCR/MR1/rRL-6-CH2OH complex shows an evolutionarily conserved binding orientation, with a clear role for both the CDR3α and CDR3β loops in recognizing the rRL-6-CH2OH stimulatory ligand. We also present two additional xenoreactive MAIT TCR/MR1 complexes that recapitulate the docking orientation documented previously, despite having variation in the CDR2β and CDR3β loop sequences. Our data support a model by which MAIT TCRs engage MR1 in a conserved fashion, with their binding affinities modulated by the nature of the MR1-presented Ag or diversity introduced by alternate Vβ usage or CDR3β sequences.

Indexed as

Antigen PresentationAntigens, BacterialCrystallography, X-RayEscherichia coliHistocompatibility Antigens Class IHumansLymphocyte ActivationMinor Histocompatibility AntigensMultiprotein ComplexesProtein BindingProtein Structure, TertiaryReceptors, Antigen, T-Cell, alpha-betaSalmonella typhimuriumT-Lymphocyte SubsetsAntigens, BacterialHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanMultiprotein ComplexesReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID24108697
PMCPMC3819123
OpenAlexW2164271365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.